FW: MMWR Vol. 62 / No. RR-7

0 views
Skip to first unread message

Maffei, Joanne

unread,
Sep 19, 2013, 12:45:55 PM9/19/13
to ls...@googlegroups.com, Bergeron, Vanessa, Berry, Sharon D., Friloux, Denise L., Gorrondona, Jeanne M., Hagan, Brenda A., Paynes, Takia S.

 

 

From: Centers for Disease Control & Prevention [mailto:c...@service.govdelivery.com]
Sent: Thursday, September 19, 2013 11:17 AM
To: Maffei, Joanne
Subject: MMWR Vol. 62 / No. RR-7

 

Having trouble viewing this email? View it as a Web page.

Image removed by sender. Bookmark and Share

If you have trouble reading this e-mail, please click here.


Image removed by sender. HHS, CDC and MMWR Logos

Image removed by sender.

Recommendations and Reports
Volume 62, No. RR-7
September 20, 2013

Image removed by sender.

Image removed by sender.

Image removed by sender.

PDF of this issue

MMWR Online

Subscriptions

Contact MMWR

CDC Homepage

Image removed by sender. MMWR RSS feedsMMWR RSS Feed
How to Add MMWR RSS feeds
Learn More About RSS

 

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization
Practices — United States,
2013–2014

Image removed by sender.

 

Image removed by sender.

This report updates the 2012 recommendations by CDC’s Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccines for the prevention and control of seasonal influenza. Routine annual influenza vaccination is recommended for all persons aged ≥6 months. For the 2013–14 influenza season, it is expected that trivalent live attenuated influenza vaccine (LAIV3) will be replaced by a quadrivalent LAIV formulation (LAIV4). Inactivated influenza vaccines (IIVs) will be available in both trivalent (IIV3) and quadrivalent (IIV4) formulations. Vaccine virus strains included in the 2013–14 U.S. trivalent influenza vaccines will be an A/California/7/2009 (H1N1)–like virus, an H3N2 virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011, and a B/Massachusetts/2/2012–like virus. Quadrivalent vaccines will include an additional influenza B virus strain, a B/Brisbane/60/2008–like virus, intended to ensure that both influenza B virus antigenic lineages (Victoria and Yamagata) are included in the vaccine. This information is intended for vaccination providers, immunization program personnel, and public
health personnel.

Image removed by sender.

Image removed by sender. full textfull text

Image removed by sender.

 


Department of Health and Human Services
Centers for Disease Control and Prevention

 


Modify/Update Subscriber Preferences  |  Unsubscribe  |  Send Feedback  |  Learn more about CDC Email Updates

To receive the latest news for your region, please update your profile with your country, state and zip code.

Questions or problems? Please contact sup...@govdelivery.com.

 

 

Image removed by sender. CDC 24/7 – Saving Lives, Protecting People, Saving Money. CDC.gov/24-7…

Image removed by sender. Dept of Health and Human Services Logo

Image removed by sender. CDC Twitter Chat www.cdc.gov/TwitterChat

 

 

 

STAY CONNECTED:

 

Image removed by sender. CDC on Facebook

 CDC on Facebook

Image removed by sender. CDC on Twitter

 Dr. Frieden on Twitter

Image removed by sender. CDC on YouTube

 CDC on YouTube

Image removed by sender. Bookmark and Share


This email was sent to jma...@lsuhsc.edu using GovDelivery, on behalf of: Centers for Disease Control and Prevention (CDC) · 1600 Clifton Rd · Atlanta, GA 30333 · 1-800-CDC-INFO (800-232-4636)

Image removed by sender. Powered by GovDelivery

Image removed by sender.



Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message.
Reply all
Reply to author
Forward
0 new messages